Olgaard K - Search Results

1

The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization.

Mace ML, Gravesen E, Nordholm A, Egstrand S, Morevati M, Olgaard K, Lewin E. Mace ML, et al. Among authors: olgaard k. JBMR Plus. 2022 Mar 1;6(4):e10610. doi: 10.1002/jbm4.10610. eCollection 2022 Apr. JBMR Plus. 2022. PMID: 35434452 Free PMC article.

2

Chronic Kidney Disease-Induced Vascular Calcification Impairs Bone Metabolism.

Mace ML, Gravesen E, Nordholm A, Egstrand S, Morevati M, Nielsen C, Kjaer A, Behets G, D'Haese P, Olgaard K, Lewin E. Mace ML, et al. Among authors: olgaard k. J Bone Miner Res. 2021 Mar;36(3):510-522. doi: 10.1002/jbmr.4203. Epub 2020 Dec 10. J Bone Miner Res. 2021. PMID: 33301619 Free PMC article.

3

New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder.

Mace ML, Egstrand S, Morevati M, Olgaard K, Lewin E. Mace ML, et al. Among authors: olgaard k. Metabolites. 2021 Dec 7;11(12):849. doi: 10.3390/metabo11120849. Metabolites. 2021. PMID: 34940607 Free PMC article. Review.

4

Can hyperparathyroid bone disease be arrested or reversed?

Olgaard K, Lewin E. Olgaard K, et al. Clin J Am Soc Nephrol. 2006 May;1(3):367-73. doi: 10.2215/CJN.01961205. Epub 2006 Mar 29. Clin J Am Soc Nephrol. 2006. PMID: 17699233 Review.

5

Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.

Gravesen E, Hofman-Bang J, Lewin E, Olgaard K. Gravesen E, et al. Among authors: olgaard k. Scand J Clin Lab Invest. 2013 Mar;73(2):107-16. doi: 10.3109/00365513.2012.744464. Epub 2013 Jan 3. Scand J Clin Lab Invest. 2013. PMID: 23281842 Clinical Trial.

6

A potential kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+.

Nordholm A, Mace ML, Gravesen E, Olgaard K, Lewin E. Nordholm A, et al. Among authors: olgaard k. BMC Nephrol. 2015 Mar 15;16:29. doi: 10.1186/s12882-015-0019-3. BMC Nephrol. 2015. PMID: 25885328 Free PMC article.

7

The vascular secret of Klotho.

Lewin E, Olgaard K. Lewin E, et al. Among authors: olgaard k. Kidney Int. 2015 Jun;87(6):1089-91. doi: 10.1038/ki.2015.80. Kidney Int. 2015. PMID: 26024025 Free article.

8

Key role of the kidney in the regulation of fibroblast growth factor 23.

Mace ML, Gravesen E, Hofman-Bang J, Olgaard K, Lewin E. Mace ML, et al. Among authors: olgaard k. Kidney Int. 2015 Dec;88(6):1304-1313. doi: 10.1038/ki.2015.231. Epub 2015 Jul 29. Kidney Int. 2015. PMID: 26221757 Free article.

9

Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.

Rukov JL, Gravesen E, Mace ML, Hofman-Bang J, Vinther J, Andersen CB, Lewin E, Olgaard K. Rukov JL, et al. Among authors: olgaard k. Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F477-91. doi: 10.1152/ajprenal.00472.2015. Epub 2016 Jan 6. Am J Physiol Renal Physiol. 2016. PMID: 26739890 Free PMC article.

10

Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.

Mace ML, Gravesen E, Nordholm A, Hofman-Bang J, Secher T, Olgaard K, Lewin E. Mace ML, et al. Among authors: olgaard k. Kidney Int. 2017 Jul;92(1):165-178. doi: 10.1016/j.kint.2017.01.015. Epub 2017 Mar 22. Kidney Int. 2017. PMID: 28341272 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page